Ya it ran .97 without the solid fundamentals that it has today. So much DD on this company, ceo just spent 200k dollars more to buy shares and has not sold one share. IMO it will easily eclipse .97 with more drug launches and the filing of the expedited NDA for a billion dollar product.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.